Vistin Pharma ASA Income Statement

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	452.29	429.09	435.39	287.68	275.81
Other Revenue	-	0.41	2.94	17.18	2.81
Revenue	452.29	429.5	438.33	304.85	278.62
Revenue Growth (YoY)	5.31%	-2.01%	43.78%	9.41%	9.74%
Cost of Revenue	151.51	149.97	176.64	138.06	96.1
Gross Profit	300.78	279.53	261.68	166.79	182.53
Selling, General & Admin	98.52	81.72	81.84	69.73	64.96
Other Operating Expenses	87.38	93.49	93.9	90.88	73.71
Operating Expenses	208.43	194.24	193.09	172.88	149.28
Operating Income	92.35	85.3	68.6	-6.1	33.25
Interest Expense	-11.02	-2.34	-2.27	-2.14	-0.36
Interest & Investment Income	14.5	0.51	0.22	0.03	0.27
Currency Exchange Gain (Loss)	-	-3.05	-7.92	2.51	-1.13
Other Non Operating Income (Expenses)	0	0.04	-0.11	-0.31	-0.03
EBT Excluding Unusual Items	95.84	80.45	58.52	-6.01	32
Pretax Income	95.84	80.45	58.52	-6.01	32
Income Tax Expense	21.09	17.7	12.92	-1.29	7.13
Earnings From Continuing Operations	74.76	62.75	45.6	-4.72	24.87
Net Income	74.76	62.75	45.6	-4.72	24.87
Net Income to Common	74.76	62.75	45.6	-4.72	24.87
Net Income Growth	19.13%	37.62%	-	-	-
Shares Outstanding (Basic)	44	44	44	44	44
Shares Outstanding (Diluted)	44	44	44	44	44
EPS (Basic)	1.69	1.42	1.03	-0.11	0.56
EPS (Diluted)	1.69	1.42	1.03	-0.11	0.56
EPS Growth	19.13%	37.62%	-	-	-
Free Cash Flow	62.03	67.05	72.69	-74.8	-18.26
Free Cash Flow Per Share	1.40	1.51	1.64	-1.69	-0.41
Dividend Per Share	1.500	1.250	1.000	0.750	0.750
Dividend Growth	20.00%	25.00%	33.33%	-	50.00%
Gross Margin	66.50%	65.08%	59.70%	54.71%	65.51%
Operating Margin	20.42%	19.86%	15.65%	-2.00%	11.93%
Profit Margin	16.53%	14.61%	10.40%	-1.55%	8.92%
Free Cash Flow Margin	13.71%	15.61%	16.58%	-24.54%	-6.55%
EBITDA	114.89	103.27	84.89	5.33	42.79
EBITDA Margin	25.40%	24.04%	19.37%	1.75%	15.36%
D&A For EBITDA	22.53	17.97	16.3	11.43	9.54
EBIT	92.35	85.3	68.6	-6.1	33.25
EBIT Margin	20.42%	19.86%	15.65%	-2.00%	11.93%
Effective Tax Rate	22.00%	22.00%	22.08%	-	22.28%
Revenue as Reported	-	429.5	438.33	304.85	278.62

Source: S&P Global Market Intelligence. Standard template. Financial Sources.